Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions.
Brandolini L, d'Angelo M, Novelli R, Castelli V, Giorgio C, Sirico A, Cocchiaro P, D'Egidio F, Benedetti E, Cristiano C, Bugatti A, Ruocco A, Amendola PG, Talarico C, Manelfi C, Iaconis D, Beccari A, Quadros AU, Cunha TM, Caruso A, Russo R, Cimini A, Aramini A, Allegretti M.
Brandolini L, et al. Among authors: giorgio c.
Cell Death Dis. 2022 May 25;13(5):500. doi: 10.1038/s41419-022-04964-w.
Cell Death Dis. 2022.
PMID: 35614037
Free PMC article.